Suppr超能文献

肝纤维化:疾病进展过程中生物标志物状态及其意义的综述

Liver fibrosis: a compilation on the biomarkers status and their significance during disease progression.

作者信息

Nallagangula Krishna Sumanth, Nagaraj Shashidhar Kurpad, Venkataswamy Lakshmaiah, Chandrappa Muninarayana

机构信息

Department of Biochemistry, Sri Devaraj Urs Medical College, SDUAHER, Tamaka, Kolar, Karnataka, India.

Department of Medicine, Sri Devaraj Urs MedicalCollege, SDUAHER, Tamaka, Kolar, Karnataka, India.

出版信息

Future Sci OA. 2017 Oct 5;4(1):FSO250. doi: 10.4155/fsoa-2017-0083. eCollection 2018 Jan.

Abstract

Liver fibrosis occurs in response to different etiologies of chronic liver injury. Diagnosing degree of liver fibrosis is a crucial step in evaluation of severity of the disease. An invasive liver biopsy is the gold standard method associated with pain and complications. Biomarkers to detect liver fibrosis include direct markers of extracellular matrix turnover and indirect markers as a reflection of liver dysfunction. Although a single marker may not be useful for successful management, a mathematical equation combining tests might be effective. The main purpose of this review is to understand the diagnostic accuracy of biomarkers and scoring systems for liver fibrosis. Advances in -omics approach have generated clinically significant biomarker candidates for liver fibrosis that need further evaluation.

摘要

肝纤维化是对不同病因的慢性肝损伤作出的反应。诊断肝纤维化程度是评估疾病严重程度的关键步骤。侵入性肝活检是与疼痛和并发症相关的金标准方法。检测肝纤维化的生物标志物包括细胞外基质周转的直接标志物和反映肝功能障碍的间接标志物。尽管单一标志物可能无助于成功治疗,但将多种检测结合的数学公式可能有效。本综述的主要目的是了解肝纤维化生物标志物和评分系统的诊断准确性。-组学方法的进展产生了具有临床意义的肝纤维化生物标志物候选物,这些候选物需要进一步评估。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/fa4a/5729599/39bb9d619122/fsoa-04-250-g1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验